Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Specific investigations: other studies

Currently viewing:

Administrative data

Endpoint:
cytotoxicity
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study well documented, meets generally accepted scientific principles, acceptable for assessment.

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
2006

Materials and methods

Principles of method if other than guideline:
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H tetrazorium bromide (MTT) assay; the cytotoxic effect of i-BMA on the cell viability of carcinoma cell line derived from salivary gland (HSG cells) and human gingval fibroblasts (HGF cells) was determined. With these cells the cytotoxic activity and the
Ca2+ mobilization activity stimulated by various monomers was investigated.
GLP compliance:
not specified
Type of method:
in vitro

Test material

Constituent 1
Chemical structure
Reference substance name:
Isobutyl methacrylate
EC Number:
202-613-0
EC Name:
Isobutyl methacrylate
Cas Number:
97-86-9
Molecular formula:
C8H14O2
IUPAC Name:
isobutyl methacrylate
Details on test material:
- Supplier: Tokyo Kasei Chem. Co., Tokyo, Japan
- Purity: commercial grade, no further purification

Administration / exposure

Doses / concentrations
Remarks:
Doses / Concentrations:

Basis:

Results and discussion

Details on results:
The cytotoxic effect of i-BMA on the cell viability of HSG cells was CC50: 0.010 mM and 0.013 mM (HGF cells) (cytotoxic concentration for 50 % cell death).

Applicant's summary and conclusion